Introduction The spectrum of SARS-CoV-2 mutations have increased over time, resulting in
the emergence of several variants of concern. Persistent infection is assumed to be involved …

Peptides are promising therapeutic agents for COVID‐19 because of their specificity, easy
synthesis, and ability to be fine‐tuned. We previously demonstrated that a cell‐permeable …

Background Cross-species transmission of zoonotic IAVs to humans is potentially
widespread and lethal, posing a great threat to human health, and their cross-species …

Human metapneumovirus (HMPV) is a leading cause of respiratory infection in adults> 65 y.
Nearly all children worldwide are seropositive for HMPV by age 5 y, but reinfections occur …

We recently established a long‐term SARS‐CoV‐2 infection model using lung‐cancer
xenograft mice and identified mutations that arose in the SARS‐CoV‐2 genome during long …

The evolution of SARS‐CoV‐2, which limits public control and treatment, seems to have
occurred through multiple mechanisms, including recombination of cocirculating strains in …

SARS-CoV-2 Omicron has the largest number of mutations among all the known SARS-CoV-
2 variants. The presence of these mutations might explain why Omicron is more infectious …

SARS-CoV-2 mutation rates have increased over time, resulting in the emergence of several
variants of concern. Persistent infection is assumed to be involved in the evolution of the …

Human metapneumovirus (HMPV) is a leading cause of severe respiratory disease in young
children< 5yrs old, older adults> 65yrs old, and the immunocompromised. HMPV immunity is …

The continuous advancement of science and medicine is pivotal in the quest to protect and
improve human health. This book aims to present the latest perspectives in the fields of …